The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J04 | Antimycobacterials | |
| 3 | J04A | Drugs for treatment of tuberculosis | |
| 4 | J04AD | Thiocarbamide derivatives |
| Code | Title | |
|---|---|---|
| J04AD01 | Protionamide | |
| J04AD02 | Tiocarlide | |
| J04AD03 | Ethionamide |
| Active Ingredient | Description | |
|---|---|---|
| Ethionamide |
Ethionamide is bacteriostatic against M. tuberculosis at therapeutic concentrations, but may be bactericidal at higher concentrations. The exact mechanism of action of ethionamide has not been fully elucidated, but the drug appears to inhibit peptide synthesis in susceptible organisms. Drug resistance develops rapidly when ethionamide is given as monotherapy. |
